Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

The N-terminal domain of the R28 protein promotes emm28 group A Streptococcus adhesion to host cells via direct binding to three integrins.

Weckel A, Ahamada D, Bellais S, Méhats C, Plainvert C, Longo M, Poyart C, Fouet A.

J Biol Chem. 2018 Oct 12;293(41):16006-16018. doi: 10.1074/jbc.RA118.004134. Epub 2018 Aug 27.

PMID:
30150299
2.

Regulation of PI-2b Pilus Expression in Hypervirulent Streptococcus agalactiae ST-17 BM110.

Périchon B, Szili N, du Merle L, Rosinski-Chupin I, Gominet M, Bellais S, Poyart C, Trieu-Cuot P, Dramsi S.

PLoS One. 2017 Jan 20;12(1):e0169840. doi: 10.1371/journal.pone.0169840. eCollection 2017.

3.

Srr2, a multifaceted adhesin expressed by ST-17 hypervirulent Group B Streptococcus involved in binding to both fibrinogen and plasminogen.

Six A, Bellais S, Bouaboud A, Fouet A, Gabriel C, Tazi A, Dramsi S, Trieu-Cuot P, Poyart C.

Mol Microbiol. 2015 Sep;97(6):1209-22. doi: 10.1111/mmi.13097. Epub 2015 Jul 17.

4.

Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.

Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, Trieu-Cuot P, Poyart C.

J Infect Dis. 2012 Dec 1;206(11):1745-52. doi: 10.1093/infdis/jis605. Epub 2012 Sep 21.

PMID:
23002446
5.

Rga, a RofA-like regulator, is the major transcriptional activator of the PI-2a pilus in Streptococcus agalactiae.

Dramsi S, Dubrac S, Konto-Ghiorghi Y, Da Cunha V, Couvé E, Glaser P, Caliot E, Débarbouillé M, Bellais S, Trieu-Cuot P, Mistou MY.

Microb Drug Resist. 2012 Jun;18(3):286-97. doi: 10.1089/mdr.2012.0005. Epub 2012 Mar 20.

PMID:
22432704
6.

Group B Streptococcus surface proteins as major determinants for meningeal tropism.

Tazi A, Bellais S, Tardieux I, Dramsi S, Trieu-Cuot P, Poyart C.

Curr Opin Microbiol. 2012 Feb;15(1):44-9. doi: 10.1016/j.mib.2011.12.002. Epub 2011 Dec 27. Review.

PMID:
22206860
7.

Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients.

Boleij A, Roelofs R, Danne C, Bellais S, Dramsi S, Kato I, Tjalsma H.

Cancer Prev Res (Phila). 2012 Feb;5(2):260-5. doi: 10.1158/1940-6207.CAPR-11-0321. Epub 2011 Oct 19.

8.

[A breakthrough in the understanding of neonatal group B streptococcus meningitis].

Tazi A, Disson O, Bellais S, Bouaboud A, Tardieux I, Trieu-Cuot P, Lecuit M, Poyart C.

Med Sci (Paris). 2011 Apr;27(4):362-4. doi: 10.1051/medsci/2011274010. Epub 2011 Apr 28. French. No abstract available.

9.

The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates.

Tazi A, Disson O, Bellais S, Bouaboud A, Dmytruk N, Dramsi S, Mistou MY, Khun H, Mechler C, Tardieux I, Trieu-Cuot P, Lecuit M, Poyart C.

J Exp Med. 2010 Oct 25;207(11):2313-22. doi: 10.1084/jem.20092594. Epub 2010 Oct 18.

10.

In vitro readthrough of termination codons by gentamycin in the Stüve-Wiedemann Syndrome.

Bellais S, Le Goff C, Dagoneau N, Munnich A, Cormier-Daire V.

Eur J Hum Genet. 2010 Jan;18(1):130-2. doi: 10.1038/ejhg.2009.122.

11.

Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome).

Geneviève D, Proulle V, Isidor B, Bellais S, Serre V, Djouadi F, Picard C, Vignon-Savoye C, Bader-Meunier B, Blanche S, de Vernejoul MC, Legeai-Mallet L, Fischer AM, Le Merrer M, Dreyfus M, Gaussem P, Munnich A, Cormier-Daire V.

Nat Genet. 2008 Mar;40(3):284-6. doi: 10.1038/ng.2007.66. Epub 2008 Feb 10.

PMID:
18264100
12.

Mutations in cytokine receptor-like factor 1 (CRLF1) account for both Crisponi and cold-induced sweating syndromes.

Dagoneau N, Bellais S, Blanchet P, Sarda P, Al-Gazali LI, Di Rocco M, Huber C, Djouadi F, Le Goff C, Munnich A, Cormier-Daire V.

Am J Hum Genet. 2007 May;80(5):966-70. Epub 2007 Mar 13.

13.

Identification of the L,D-transpeptidases responsible for attachment of the Braun lipoprotein to Escherichia coli peptidoglycan.

Magnet S, Bellais S, Dubost L, Fourgeaud M, Mainardi JL, Petit-Frère S, Marie A, Mengin-Lecreulx D, Arthur M, Gutmann L.

J Bacteriol. 2007 May;189(10):3927-31. Epub 2007 Mar 16.

14.

Aslfm, the D-aspartate ligase responsible for the addition of D-aspartic acid onto the peptidoglycan precursor of Enterococcus faecium.

Bellais S, Arthur M, Dubost L, Hugonnet JE, Gutmann L, van Heijenoort J, Legrand R, Brouard JP, Rice L, Mainardi JL.

J Biol Chem. 2006 Apr 28;281(17):11586-94. Epub 2006 Feb 28.

15.

Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faecium.

Rice LB, Bellais S, Carias LL, Hutton-Thomas R, Bonomo RA, Caspers P, Page MG, Gutmann L.

Antimicrob Agents Chemother. 2004 Aug;48(8):3028-32.

16.

Molecular and biochemical characterization of a carbapenem-hydrolysing beta-lactamase from Flavobacterium johnsoniae.

Naas T, Bellais S, Nordmann P.

J Antimicrob Chemother. 2003 Feb;51(2):267-73.

PMID:
12562690
18.

EBR-1, a novel Ambler subclass B1 beta-lactamase from Empedobacter brevis.

Bellais S, Girlich D, Karim A, Nordmann P.

Antimicrob Agents Chemother. 2002 Oct;46(10):3223-7.

19.
20.

Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.

Bellais S, Mimoz O, Léotard S, Jacolot A, Petitjean O, Nordmann P.

Antimicrob Agents Chemother. 2002 Jun;46(6):2032-4.

21.
22.

First isolation of a carbapenem-hydrolyzing beta-lactamase in Pseudomonas aeruginosa in Spain.

Prats G, Miro E, Mirelis B, Poirel L, Bellais S, Nordmann P.

Antimicrob Agents Chemother. 2002 Mar;46(3):932-3. No abstract available.

23.

Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis.

Bellais S, Poirel L, Fortineau N, Decousser JW, Nordmann P.

Antimicrob Agents Chemother. 2001 Oct;45(10):2965-8.

24.

Heterogeneity of AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes.

Girlich D, Naas T, Bellais S, Poirel L, Karim A, Nordmann P.

Antimicrob Agents Chemother. 2000 Nov;44(11):3220-3.

25.

Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes.

Bellais S, Poirel L, Leotard S, Naas T, Nordmann P.

Antimicrob Agents Chemother. 2000 Nov;44(11):3028-34.

26.

Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum.

Bellais S, Aubert D, Naas T, Nordmann P.

Antimicrob Agents Chemother. 2000 Jul;44(7):1878-86.

27.

Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei.

Girlich D, Naas T, Bellais S, Poirel L, Karim A, Nordmann P.

Antimicrob Agents Chemother. 2000 Jun;44(6):1470-8.

28.

Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P.

Antimicrob Agents Chemother. 2000 Apr;44(4):891-7.

31.

Molecular characterization of a carbapenem-hydrolyzing beta-lactamase from Chryseobacterium (Flavobacterium) indologenes.

Bellais S, Léotard S, Poirel L, Naas T, Nordmann P.

FEMS Microbiol Lett. 1999 Feb 15;171(2):127-32.

Supplemental Content

Loading ...
Support Center